530156-90-2 Usage
Uses
Used in Pharmaceutical Applications:
2-Bromo-5-chloro-isonicotinic acid is used as a building block in the synthesis of bioactive compounds for its anti-inflammatory and anti-cancer properties. It has been studied for its potential use in the development of new drugs, offering therapeutic benefits in various medical conditions.
Used in Agrochemical Applications:
2-Bromo-5-chloro-isonicotinic acid is used as an intermediate in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural chemicals to protect crops and enhance agricultural productivity.
Used in Organic Synthesis:
2-Bromo-5-chloro-isonicotinic acid is used as a valuable intermediate in organic synthesis, enabling the creation of a wide range of chemical compounds with diverse applications in various industries.
Used in Chemical Research:
2-Bromo-5-chloro-isonicotinic acid serves as a useful compound in chemical research, aiding scientists in understanding the structure, properties, and potential applications of this versatile molecule, and contributing to the advancement of chemical knowledge and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 530156-90-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,0,1,5 and 6 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 530156-90:
(8*5)+(7*3)+(6*0)+(5*1)+(4*5)+(3*6)+(2*9)+(1*0)=122
122 % 10 = 2
So 530156-90-2 is a valid CAS Registry Number.
530156-90-2Relevant academic research and scientific papers
Azacyclic derivative as well as preparation method and medical use thereof
-
Paragraph 0269; 0270; 0271; 0272, (2019/02/04)
The invention relates to an azacyclic derivative as well as a preparation method and medical use thereof and particularly relates to an azacyclic derivative represented by a general formula (I) (shownin the description), a preparation method thereof, a pharmaceutical composition containing the derivative and use of the derivative as an SMO antagonist, particularly in the treatment of diseases such as cancer related to Hedgehog signal channels. The definitions of groups in the general formula (I) are same as the definitions in the description.
